Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
{
"resourceType" : "MedicationRequest",
"id" : "medicationrequest-for-bresentrik",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medicationrequest-for-bresentrik\"> </a><a name=\"hcmedicationrequest-for-bresentrik\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest "medicationrequest-for-bresentrik" </p></div><p><b>identifier</b>: <code>http://www.bmc.nl/portal/medstatements</code>/1234568900-studyDrug\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Medication-bresentrik.html\">Medication/bresentrik: bresentrik 2mg tablet</a></td></tr></table><p><b>subject</b>: <a href=\"Patient-JanetPatient.html\">Patient/JanetPatient: Janet</a> " CLINICAL TRIAL PATIENT"</p><p><b>supportingInformation</b>: <a href=\"ResearchStudy-BreastCancerTrial.html\">ResearchStudy/BreastCancerTrial: http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy</a></p><p><b>authoredOn</b>: 2023-04-05</p><p><b>requester</b>: <span>: Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD</span></p><h3>Reasons</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Breast Cancer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#254837009)</span></td></tr></table><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</p><p><b>timing</b>: Once per 1 days</p><p><b>route</b>: Oral route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dispenseRequest</b></p><p><b>numberOfRepeatsAllowed</b>: 1</p><p><b>quantity</b>: 600 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><h3>ExpectedSupplyDurations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Value</b></td><td><b>Unit</b></td><td><b>System</b></td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>30</td><td>days</td><td><a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ucum.html\">Unified Code for Units of Measure (UCUM)</a></td><td>d</td></tr></table></blockquote></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "http://www.bmc.nl/portal/medstatements",
"value" : "1234568900-studyDrug"
}
],
"status" : "active",
"intent" : "order",
"medication" : {
"reference" : {
🔗 "reference" : "Medication/bresentrik",
"display" : "bresentrik 2mg tablet"
}
},
"subject" : {
🔗 "reference" : "Patient/JanetPatient",
"display" : "Janet"
},
"supportingInformation" : [
{
🔗 "reference" : "ResearchStudy/BreastCancerTrial",
"display" : "http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy"
}
],
"authoredOn" : "2023-04-05",
"requester" : {
"display" : "Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD"
},
"reason" : [
{
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "254837009",
"display" : "Breast Cancer"
}
]
}
}
],
"dosageInstruction" : [
{
"sequence" : 1,
"text" : "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL",
"timing" : {
"repeat" : {
"frequency" : 1,
"period" : 1,
"periodUnit" : "d"
}
},
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "26643006",
"display" : "Oral route (qualifier value)"
}
]
},
"doseAndRate" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}
]
},
"doseQuantity" : {
"value" : 6,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}
]
}
],
"dispenseRequest" : {
"numberOfRepeatsAllowed" : 1,
"quantity" : {
"value" : 600,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"expectedSupplyDuration" : {
"value" : 30,
"unit" : "days",
"system" : "http://unitsofmeasure.org",
"code" : "d"
}
}
}